↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Tyck till om SwePub Sök här!

Träfflista för sökning "WFRF:(Dick D) "

Search: WFRF:(Dick D)

Result 1-10 of 153

Sort/group result

Sort by: Hits per page:

Enumeration	Reference	Cover	Find
1.	2021 swepub:Mat__t
2.	Bonaca, MP, et al. (author) Long-term use of ticagrelor in patients with prior myocardial infarction 2015 In: The New England journal of medicine. - 1533-4406. ; 372:19, s. 1791-1800 Journal article (peer-reviewed)
3.	Thomas, HS, et al. (author) 2019 swepub:Mat__t
4.	Bhangu, A, et al. (author) Surgical site infection after gastrointestinal surgery in high-income, middle-income, and low-income countries: a prospective, international, multicentre cohort study 2018 In: The Lancet. Infectious diseases. - : Elsevier. - 1474-4457 .- 1473-3099. ; 18:5, s. 516-525 Journal article (peer-reviewed)
5.	Acharya, B. S., et al. (author) Introducing the CTA concept 2013 In: Astroparticle physics. - : Elsevier BV. - 0927-6505 .- 1873-2852. ; 43, s. 3-18 Journal article (other academic/artistic)abstract The Cherenkov Telescope Array (CTA) is a new observatory for very high-energy (VHE) gamma rays. CTA has ambitions science goals, for which it is necessary to achieve full-sky coverage, to improve the sensitivity by about an order of magnitude, to span about four decades of energy, from a few tens of GeV to above 100 TeV with enhanced angular and energy resolutions over existing VHE gamma-ray observatories. An international collaboration has formed with more than 1000 members from 27 countries in Europe, Asia, Africa and North and South America. In 2010 the CTA Consortium completed a Design Study and started a three-year Preparatory Phase which leads to production readiness of CTA in 2014. In this paper we introduce the science goals and the concept of CTA, and provide an overview of the project. (C) 2013 Elsevier B.V. All rights reserved.
6.	Szarek, M, et al. (author) Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial 2019 In: Circulation. Cardiovascular quality and outcomes. - : Ovid Technologies (Wolters Kluwer Health). - 1941-7705 .- 1941-7713. ; 12:11, s. e005858- Journal article (peer-reviewed)
7.	Jukema, JW, et al. (author) Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial 2019 In: Journal of the American College of Cardiology. - : Elsevier BV. - 1558-3597 .- 0735-1097. ; 74:9, s. 1167-1176 Journal article (peer-reviewed)
8.	Ray, KK, et al. (author) Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 2019 In: The lancet. Diabetes & endocrinology. - 2213-8595 .- 2213-8587. ; 7:8, s. 618-628 Journal article (peer-reviewed)
9.	Roe, MT, et al. (author) Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes 2019 In: Circulation. - : Ovid Technologies (Wolters Kluwer Health). - 1524-4539 .- 0009-7322. ; 140:19, s. 1578-1589 Journal article (peer-reviewed)
10.	Steg, PG, et al. (author) Effect of Alirocumab on Mortality After Acute Coronary Syndromes 2019 In: Circulation. - 1524-4539. ; 140:2, s. 103-112 Journal article (peer-reviewed)

Skapa referenser, mejla, bekava och länka

Permalink

Result 1-10 of 153

Refine your search

Type of publication: journal article (134); conference paper (10); research review (4); editorial collection (1); doctoral thesis (1); book chapter (1); show more...; show less...

Type of content: peer-reviewed (131); other academic/artistic (20)

Author/Editor: Rujescu, D (19); Kaprio, J (17); Graff, C (17); Galimberti, D (17); Lichtenstein, P. (14); Palotie, A (14); show more...; Le Hellard, S (13); Masellis, M (13); Borroni, B. (13); Breen, G (12); Cichon, S (12); Widen, E (12); Hakonarson, H (12); Herms, S. (12); Egberts, K. (11); Thompson, Paul M (11); Heinegård, Dick (11); Ripke, S (11); Reichborn-Kjennerud, ... (11); Tagliavini, F (11); Roberts, M. (10); Ching, Christopher R ... (10); Martin, NG (10); Ripatti, S (10); Jahanshad, Neda (10); Veltman, Dick J (10); Guo, Y (9); Palviainen, T (9); Li, D. (9); Foretova, L (9); Harding, S (9); Schmidt, U. (9); Steiner, S. (9); Janik, M (9); Alfredsson, L (9); Ehrlich, S (9); Espeseth, T (9); Lissowska, J (9); Lahti, J (9); Dina, C (9); Metspalu, A (9); Jimenez-Murcia, S (9); Hauser, J. (9); Tortorella, A. (9); Monteleone, P. (9); Maj, M. (9); Gill, M. (9); Navratilova, M (9); Treasure, J (9); Stein, Dan J (9); show less...

University: Karolinska Institutet (76); Uppsala University (36); University of Gothenburg (29); Lund University (19); Stockholm University (16); Umeå University (14); show more...; Linköping University (6); Linnaeus University (5); Royal Institute of Technology (4); Örebro University (3); Chalmers University of Technology (3); Swedish University of Agricultural Sciences (3); Jönköping University (2); Mid Sweden University (2); Karlstad University (2); Luleå University of Technology (1); Stockholm School of Economics (1); Swedish Museum of Natural History (1); show less...

Language: English (152); Swedish (1)

Research subject (UKÄ/SCB): Medical and Health Sciences (70); Natural sciences (32); Social Sciences (5); Agricultural Sciences (3); Engineering and Technology (1); Humanities (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - National Library Systems
LIBRIS.kb.se

pil uppåt

Close

Copy and save the link in order to return to this view